ASX:M7T

Mach7 Technologies Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume272,627 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Mach7 Technologies (ASX:M7T) Vs. 1ST, ALC, BNVIF, CNNA, CNONF, and DOCRF

Should you be buying M7T stock or one of its competitors? Companies in the industry of "health information services" are considered alternatives and competitors to Mach7 Technologies, including 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), CannaOne Technologies (CNONF), and CloudMD Software & Services (DOCRF).

Mach7 Technologies (ASX:M7T) and 1st Group (ASX:1ST) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, analyst recommendations, profitability, earnings and risk.

Analyst Ratings

This is a breakdown of current ratings for Mach7 Technologies and 1st Group, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mach7 Technologies0000N/A
1st Group0000N/A

Earnings and Valuation

This table compares Mach7 Technologies and 1st Group's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mach7 Technologies$16.89 million0.00$-8,467,344.00A($0.04)N/A
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A

1st Group has lower revenue, but higher earnings than Mach7 Technologies.

Profitability

This table compares Mach7 Technologies and 1st Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mach7 TechnologiesN/AN/AN/A
1st GroupN/AN/AN/A

Summary

1st Group beats Mach7 Technologies on 2 of the 3 factors compared between the two stocks.

Alcidion Group (ASX:ALC) and Mach7 Technologies (ASX:M7T) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, profitability, analyst recommendations, risk and valuation.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Alcidion Group and Mach7 Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Alcidion Group0000N/A
Mach7 Technologies0000N/A

Profitability

This table compares Alcidion Group and Mach7 Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Alcidion GroupN/AN/AN/A
Mach7 TechnologiesN/AN/AN/A

Earnings & Valuation

This table compares Alcidion Group and Mach7 Technologies' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alcidion Group$21.55 million0.00$-2,972,082.05A$0.00N/A
Mach7 Technologies$16.89 million0.00$-8,467,344.00A($0.04)N/A

Alcidion Group has higher revenue and earnings than Mach7 Technologies.

Summary

Alcidion Group beats Mach7 Technologies on 3 of the 3 factors compared between the two stocks.

Mach7 Technologies (ASX:M7T) and Binovi Technologies (OTCMKTS:BNVIF) are both computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, risk, institutional ownership and dividends.

Analyst Ratings

This is a summary of recent ratings and price targets for Mach7 Technologies and Binovi Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mach7 Technologies0000N/A
Binovi Technologies0000N/A

Profitability

This table compares Mach7 Technologies and Binovi Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mach7 TechnologiesN/AN/AN/A
Binovi TechnologiesN/AN/AN/A

Earnings and Valuation

This table compares Mach7 Technologies and Binovi Technologies' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mach7 Technologies$16.89 million0.00$-8,467,344.00A($0.04)N/A
Binovi TechnologiesN/AN/AN/AN/AN/A

Binovi Technologies has lower revenue, but higher earnings than Mach7 Technologies.

Summary

Mach7 Technologies beats Binovi Technologies on 1 of the 1 factors compared between the two stocks.

Mach7 Technologies (ASX:M7T) and Cann American (CNSX:CNNA) are both computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, risk, institutional ownership and dividends.

Earnings and Valuation

This table compares Mach7 Technologies and Cann American's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mach7 Technologies$16.89 million0.00$-8,467,344.00A($0.04)N/A
Cann AmericanN/AN/AN/AN/AN/A

Cann American has lower revenue, but higher earnings than Mach7 Technologies.

Analyst Ratings

This is a summary of recent ratings and price targets for Mach7 Technologies and Cann American, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mach7 Technologies0000N/A
Cann American0000N/A

Profitability

This table compares Mach7 Technologies and Cann American's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mach7 TechnologiesN/AN/AN/A
Cann AmericanN/AN/AN/A

Summary

Mach7 Technologies beats Cann American on 1 of the 1 factors compared between the two stocks.

Mach7 Technologies (ASX:M7T) and CannaOne Technologies (OTCMKTS:CNONF) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends.

Valuation & Earnings

This table compares Mach7 Technologies and CannaOne Technologies' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mach7 Technologies$16.89 million0.00$-8,467,344.00A($0.04)N/A
CannaOne TechnologiesN/AN/AN/AN/AN/A

CannaOne Technologies has lower revenue, but higher earnings than Mach7 Technologies.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Mach7 Technologies and CannaOne Technologies, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mach7 Technologies0000N/A
CannaOne Technologies0000N/A

Profitability

This table compares Mach7 Technologies and CannaOne Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mach7 TechnologiesN/AN/AN/A
CannaOne TechnologiesN/AN/AN/A

Summary

Mach7 Technologies beats CannaOne Technologies on 1 of the 1 factors compared between the two stocks.

Mach7 Technologies (ASX:M7T) and CloudMD Software & Services (OTCMKTS:DOCRF) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends.

Valuation & Earnings

This table compares Mach7 Technologies and CloudMD Software & Services' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mach7 Technologies$16.89 million0.00$-8,467,344.00A($0.04)N/A
CloudMD Software & ServicesN/AN/AN/AN/AN/A

CloudMD Software & Services has lower revenue, but higher earnings than Mach7 Technologies.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Mach7 Technologies and CloudMD Software & Services, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mach7 Technologies0000N/A
CloudMD Software & Services00203.00

CloudMD Software & Services has a consensus target price of $3.3750, suggesting a potential upside of 113.61%.

Profitability

This table compares Mach7 Technologies and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mach7 TechnologiesN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A


Mach7 Technologies Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
1st Group logo
1ST
1st Group
0.5N/AN/A$0.00$5.11 million0.00High Trading Volume
Gap Up
ALC
Alcidion Group
0.5N/AN/A$0.00$21.55 million0.00High Trading Volume
Gap Up
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.06flat$0.00N/A0.00News Coverage
Gap Down
CNNA
Cann American
0.5N/AN/A$0.00N/A0.00High Trading Volume
CannaOne Technologies logo
CNONF
CannaOne Technologies
0.6$1.03flat$0.00N/A0.00
CloudMD Software & Services logo
DOCRF
CloudMD Software & Services
1.7$1.58flat$0.00N/A0.00Gap Up
DOC
CloudMD Software & Services
1.2$1.92flatC$0.00C$11.65 million-21.33Gap Up
CGS
Cogstate
0.5N/AN/A$0.00$28.82 million0.00High Trading Volume
Gap Up
COO
Corum Group
0.5N/AN/A$0.00$12.27 million0.00High Trading Volume
EGF Theramed Health logo
EVAHF
EGF Theramed Health
0.0$0.10flat$0.00N/A0.00
EMD
Emyria
0.6N/AN/A$0.00$1.73 million0.00High Trading Volume
Gap Up
EWLL
eWellness Healthcare
0.6$0.00flat$0.00N/A0.00Gap Up
FORA
Forian
0.3$12.71flat$0.00N/A0.00Gap Down
GLH
Global Health
0.5N/AN/A$0.00$6.77 million0.00High Trading Volume
Gap Up
ICS
ICS Global
0.9N/AN/A$0.00$6.08 million0.00High Trading Volume
Gap Up
JHL
Jayex Healthcare
0.7N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
M3 logo
MTHRF
M3
1.0$76.00flat$0.00N/A0.00
MDR
MedAdvisor
0.5N/AN/A$0.00$18.09 million0.00High Trading Volume
Gap Up
NEWUF
Newtopia
1.7$0.41flat$0.00N/A0.00
NHL
Novita Healthcare
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ONE
Oneview Healthcare
0.5N/AN/A$0.00$7.10 million0.00High Trading Volume
OPL
Opyl
0.0N/AN/A$0.00$741,494.000.00High Trading Volume
PCK
PainChek
0.0N/AN/A$0.00$240,424.000.00High Trading Volume
PANHF
Ping An Healthcare and Technology
1.0$12.01flat$0.00N/A0.00News Coverage
PKS
PKS
0.0N/AN/A$0.00$5.97 million0.00High Trading Volume
PME
Pro Medicus
0.7N/AN/A$0.00$59.12 million0.00High Trading Volume
Gap Up
Pro Medicus logo
PMCUF
Pro Medicus
0.5$35.65flat$0.00N/A0.00
RAP
ResApp Health
0.9N/AN/A$0.00$46,197.000.00High Trading Volume
Gap Up
CBIIF
Skylight Health Group
0.0$0.91flat$0.00N/A0.00News Coverage
TD1
TALi Digital
0.5N/AN/A$0.00$706,550.000.00High Trading Volume
UCBB
US-China Biomedical Technology
0.3$0.34flat$0.00N/A0.00Gap Down
WELL Health Technologies logo
WLYYF
WELL Health Technologies
1.6$5.72flat$0.00N/A0.00
ZMD
ZoomMed
0.4$0.02flatC$0.00C$10,000.00-1.36Gap Down
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.